ertu medical technologies groupvertumedicaltechnologies.com/wp-content/uploads/2020/01/... ·...
TRANSCRIPT
ertu Medical Technologies Group
The Collaborative Endeavor Opportunities (CEO) Division that produces, markets products and oversees businesses generated from PIN
The Plexus Healthcare Technology Development Network or Plexus Innovation Network (PIN)
The Aegis Medical Technology Fund that can support C.E.O. projects and outside businesses with venture capital eventually providing a return to investors.
A Holding Company with 3 Core Divisions
The Problems
Innovation Processes are Top Down instead of Bottom Up
Frontline healthcare providers are not incentivizedto create technical innovations with profit sharing or royalties and are financially constrained without access to corporate R & D budgets.
Medical technology Development cycles are too long, resulting in less innovation.
As one example, the current IP development, processing and approval process is backlogged by over 750,000 U.S. patents pending
IP & Funding Restrictions for Frontline Healthcare providers.
Medical IP & Funding is owned and controlled by a select group of corporations instead of shared.
Global IP filing is prohibitively expensive and complex.
Patent infringement cases crossing borders also present legal framework challenges and patent law disparities that make global IP protection difficult to achieve or enforce.
The Solutions
Incentive Innovators
Distribute the ownership of
healthcare IP to its frontline
providers using the IP
blockchain
Create a Fund
Create a medical technology
investment resource that will
help fund the innovation
provider network
Simplify Patents
Help resolve the patent
process backlog by applying
tokens that replace the
concept of patent filings with
blockchain titles
Create a global healthcare
innovation provider network
that share the load to get to
market faster with improved
products
IP Tracking
Develop an IP tracking
system for use from concept
to completion with a utility
token.
Share the Success
Develop a platform for
distributing IP royalty
payments throughout the
development network.
Reduce the Cost & Time
Vertu Is Already Conceiving 10 Innovations
~$250m / Per Innovation
Estimate Per Innovation Value
If calculated at a conservative 5%
>$7 Trillion
Industry Value
Expected to grow >$10 Trillion by 2022
$2.5 Billion
Value of Innovations
Yearly Revenue
25%
Growth
MARKET PROJECTION
Market value expected to
increase 5% Annually,
increasing over
$3 Trillion by 2022
$10
$15
$20
2016 2018 2020 2022 2024
Surgical Equipment Market Forecast
Market
Value($ bln)
Reference: Grand View Research Inc, July, 2017 <https://www.grandviewresearch.com/press-release/global-surgical-equipment-market>
Market Research
SolutionsJohnson & Johnson Medtronics
Funding Support for Innovators
Creating Innovative Products
Accessible Product to Market Route
Innovator’s Patent Recognition &
Royalties
Patent Filing Platform
Accessible Innovation Provider
Network
Bayer
+$340 Billion +$50 Billion +$39 Billion
Competitors Comparison
VERTU MEDICAL TECHNOLOGIES
GROUP OF COMPANIES
AEGIS FUNDPLEXUS DEVELOPMENT
NETWORKCEO NETWORK
PLEXUS IPBLOCKCHAIN SaaS
STO, IEO, PLEXUS
PROJECTS &
BUSINESSES FUND
ROYALTY INCOME
GENERATES,
COORDINATES &
RECORDS
INNOVATIONS
FEEDS CEO SUPPORTS PLEXUS
DEVELOPS
INNOVATIONS &
BUSINESSES
INCOME SOURCE
FROM PDN AS SaaS
FEEDS ROYALTY
SYSTEM & AEGIS W/
ROYALTY
INNOVATIONS
TRACKS ALL PDN
ACTIVITIES, USES PLX
TOKEN
OFFERS
MANAGEMENT
TRACKS, USES PLX
TOKEN
DISTRIBUTE
DIVIDENDS, USES
AFT TOKENS
The Ecosystem
What We’ve AchievedLegal Business Entities Established
2018
Vertu Realities
2019
Innovations Progressed
Office & Facility construction.
Domains purchased
10 of the 90 innovations progressing. One of the
innovations almost ready for market.
Self Funded
Spend Thus Far: $1,000,000 USD
Innovation Ready for Scaling
$100m+ Potential
Q4 2019
Phase 1
Q2 2020
Phase 2
Fund Raise: $1 mil
Activity: Form core management team for Plexus, CEO, and Aegis Fund divisions
Begin Plexus IP blockchain development
Move most promising innovations through approval to royalty agreements.
Establish Aegis Fund board, CIO, criteria, and disbursement fund accounts.
Fund Raise: $3-5 mil
Activity: Plexus IP blockchain alpha phase testnet
Complete testing for one innovation & introduce to market
Initiate Aegis Fund investments for PI Network, businesses, and CEO activities
Begin offering CEO services to Plexus network partners and external companies
Progress can be achieved and scaling undertaken with either
the completion and progress to market of the Innovation, or
the undertaking of a public sale.
IEO or Innovation
Q2 2020
Phase 2
Fund Raise: $5-15 mil
Activity: Complete Plexus testnet and mainnet.
Complete beta protocol.
Set roll-out date for market introduction as a U.S. centric IP blockchain.
One innovation achieves market introduction and begins generating royalty payments for the
Aegis Fund. Other innovations move to prototype stages.
Roadmap
Incredible Growth
Timeline End
2021
Aegis funds innovations, produces dividends from previous medically oriented investments, funds
more innovations, seeds medical start-ups, begins paying dividends to AFT holders.
The CEO services division provides conceptual to production manufacturing and management
support for innovations now with linked suppliers and in-house assembly, testing, and marketing
functions.
This is based on a realistic raise structure. Getting
lower or higher amounts will affect the speed of this
progression.
Revenue will scale rapidly from the indicative $7M as
the innovations are released and further innovators
join.
Roadmap Timeline
Total: 6 Years
Revenue: $26M USD p.a
For 10 innovations
Total Raise: $15M-100M USD
2022
Activity: Plexus IP blocknet branches to global access in the key major languages of innovation
centers (China, U.S., Japan, South Korea, Eurozone, Germany, Russia, India, Canada, Brazil).
Multiple Plexus innovations reach market introduction, producing a growing stream of royalty
income of an estimated $XX million per year.
The Aegis Fund continues paying dividends, supporting Plexus network innovations, venture
funding medical start-ups, and appreciating assets under management to return an increasing
dividend to AFT holders.
The CEO services division expands in-house manufacturing capability, logistics, and management
as the Plexus network continues feeding innovations through the CEO business building process.
CEO services will be cash flow positive.
Revenue
COGS
Operating
NET INCOME
0.12
0.365
0.52
-0.76
4.47
2.424
1.08
0.95
7.5
3.862
1.06
2.6
Source 2020 2022 20242020
2021
2022
2023
2024
-636%
-14%
+21%
+32%
+34%
Financial Projection
Percentage Profit of Total Revenue
This projects only a single Innovation’s performance and return.
Vertu Realities directly has over 90 innovations prepared, 10 of which are presented in the White Paper.
Using this innovation as a stepping stone, Vertu Realities will see Exponential Growth
(Millions USD) (Millions USD) (Millions USD)
Fundraising Plans
Private Sale
Based on Fundraising amount, two paths can be undertaken. A further
public sale via IEO, or a product innovation launch
IEO 1.0
Reliant on market condition, should the private sale not prove to be as
fruitful, a public raise will then be undertaken.
Product Launch
One of the innovations will be brought to Market. The innovation’s
projected revenues will allow the company to grow sustainably without
further funding.
Series A
Larger sum of funding will be sought to scale the model aggressively
once the proof of concept has been established.
1
2
3
4
26%
3%
7%
11%14%
18%
21%
Dividends
Expenses
Fund
MarketingDevelopment
Product Building
Operating Expenses
Pre-Seed Target
Funds Distribution
$1,680,000 USD
Aegis Fund Tokenomics
Classification: Security TokenFull Name: Aegis Fund TokenToken Code: AFTInitial issuance: 1,009,003,247Protocol: ETH or EOS standardNetwork: Public, distributed qualified investors, developers, and Aegis FundConfirmation: PoS or DPoSSpeed: > 25 tpsConfirmation time: <10 secondsDevelopment language: Solidity or C++Limit of Issuance: 1,459,003,247Original Value: $0.10 early access.Servers Required: None. Runs on public, decentralized network.
Token distribution:
Initial sale – 15%: 151,350,487 AFTBonuses – 10%: 100,900,325 AFT
Retained by Aegis Team – 12% (6-24-month lock-up period): 121,080,390 AFT
Retained for Funding Allocation – 63%: 635,672,046 AFTD.
Dr. Richard A. Foster, MD
Co-Owner Vertu Realities LLC, Board member American Society of Chief Executive
Officers
35 year experience Emergency Medicine &
Trauma Physician
Parish Coroner reelected 18 years
Entrepreneur & Innovator
CEO & Founder IntelecomTechnologies
Board of Directors Japan Karate Association American Federation, 6th Degree Black
Belt, current US Karate National & Olympic Team
Coach
Extensive experience in motivational leadership,
computer and telecommunication
Dr. Dennis J. Morris, MD
CEO & Founder: Vertu Realities LLC, Vertu Medical
Technologies, American Society of Chief Executive Officers
35 year experience Emergency Medicine & Trauma Physician
Entrepreneur & Innovator with extensive I.P. portfolio
Extensive executive leadership experience
Chief Financial Officer & Board of Directors: Vertu
Realities LLC, Vertu Medical Technologies, American
Association of Chief Executive Officers
Escrow & Custodial Advisory
Director of National Project Management Division
Entrepreneur & Innovator
The Team
International Blockchain Consulting
Leaders in the Blockchain industry for expertise in
marketing, capital raising, technical development and business advice.
Mark Solomon
Career in engineering and R&D, transitioned to a
licensed financial adviser, commodities trader, online marketing consultant, and author of multiple financial books including one of the early books about Bitcoin.
Associates & Advisors
ertu Medical Technologies Group
@vertumedicaltechnologies
www.vertumedicaltechnologies.com